# Robert F. Vizza Clinical Accelerator Initiative

The Clinical Accelerator Initiative (CAI) advances the mission of the Lustgarten Foundation by accelerating the translation of research discoveries into the clinic. CAI studies are highly collaborative, science-driven and typically small in order to support deep translational analyses and as many learnings as possible.

Canonical page: https://grantsonar.com/grants/opportunity/robert-f-vizza-clinical-accelerator-initiative-222fbc43-9252-452d-b405-0cf8d1b4d25c
Source: funder_site
Source ID: 311611837:robert-f-vizza-clinical-accelerator-initiative
Last confirmed Aug 24, 2026 · Funder website
Deadline: November 2, 2026
Award size: not disclosed

## Answer-first Q&A

### Who is eligible for Robert F. Vizza Clinical Accelerator Initiative?

Robert F. Vizza Clinical Accelerator Initiative eligibility includes eligible applicants named in the notice. Geographic eligibility is MA, CA, NY, PA, NC, CT, MD and MI; applicants should confirm the source notice before applying.

### What is the deadline for Robert F. Vizza Clinical Accelerator Initiative?

Robert F. Vizza Clinical Accelerator Initiative has a listed deadline of November 2, 2026. Grant deadlines can change, so verify the current date with MARC LUSTGARTEN PANCREATIC CANCER before submitting.

### How much funding is available for Robert F. Vizza Clinical Accelerator Initiative?

Robert F. Vizza Clinical Accelerator Initiative lists an award size of not disclosed. Award ranges and total program funding are reported from the source metadata when available.

### Who funds Robert F. Vizza Clinical Accelerator Initiative?

Robert F. Vizza Clinical Accelerator Initiative is funded by MARC LUSTGARTEN PANCREATIC CANCER. GrantSonar tracks the notice with source ID 311611837:robert-f-vizza-clinical-accelerator-initiative from funder_site.